Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SVT 3A4710

Next Previous
X
Search
Drug Profile

SVT 3A4710

Alternative Names: SVT-3A4710

Latest Information Update: 04 Feb 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Servatus Biopharmaceuticals
  • Class Anti-inflammatories; Bacteria; Skin disorder therapies
  • Mechanism of Action Bacteria replacements; Gastrointestinal microbiome modulators; Microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Atopic dermatitis; Inflammatory bowel diseases; Skin disorders

Most Recent Events

  • 03 Feb 2021 Servatus Biopharmaceuticals holds published patents in World, China and Singapore, and pending applications in Europe, Canada, Japan, USA and Australia, related to microbial biotherapeutics for the treatment of various indications, including gastrointestinal and inflammatory diseases, prior to February 2021
  • 03 Feb 2021 Preclinical trials in Atopic dermatitis in Australia (Servatus Biopharmaceuticals pipeline, February 2021)
  • 03 Feb 2021 Preclinical trials in Inflammatory bowel diseases (Colitis) in Australia (Servatus Biopharmaceuticals pipeline, February 2021)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top